Skip to content
lifestyle.onlygolfnews.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
EIT Pharma
EIT Pharma Presents New Lonafarnib Analyses at the 2026 Delta Cure International Meeting
October 20, 2026
EIT Pharma to Sponsor and Present at the 2026 Delta Cure International Meeting
October 13, 2026
EIT Pharma Closes Oversubscribed $35 Million Series A Round, Led by Propel Bio Partners
August 31, 2026
EIT Pharma Announces FDA Acceptance of New Drug Application for Lonafarnib for Treatment of Chronic Hepatitis D
August 11, 2026
EIT Pharma Highlights New Lonafarnib Analyses at EASL Congress 2026
June 1, 2026